Weigao’s Dialysis Business Seeks Hong Kong IPO in MedTech Boom
Shandong Weigao Group's blood purification business has applied to list on the Hong Kong Stock Exchange, aiming to become the group’s fourth listed company Key Takeaways: Weigao Blood Purification filed…
Recent Articles
RELATED ARTICLES
-
Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
CARsgen seeks cell therapy breakthrough but stays in the red for now
2171.HK
- Huoli rides China travel boom to Hong Kong IPO
- 52Toys taps China’s designer toy boom in play for Hong Kong IPO
- Breton eyes big haul from investors with Hong Kong IPO plan
-
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK
